Tenax Therapeutics (NASDAQ:TENX) Coverage Initiated at StockNews.com

Equities research analysts at StockNews.com initiated coverage on shares of Tenax Therapeutics (NASDAQ:TENX – Get Free Report) in a research note issued to investors on Thursday. The firm set a “sell” rating on the specialty pharmaceutical company’s stock. A number of other brokerages also recently issued reports on TENX. Leerink Partners set a $20.00 price […]

Leave a Reply

Your email address will not be published.

Previous post Lamb Weston (NYSE:LW) Raised to Hold at StockNews.com
Next post Kenvue (NYSE:KVUE) Reaches New 52-Week High After Strong Earnings